Month: April 2020

– Company’s 12th Commercially Available XBAW Filter –– New Drone Filter was Designed and Shipped to Customer Within Three Months –– Company Rapidly Expanding Its Filter Product Portfolio for Multiple Wireless Markets –Charlotte, N.C., April 29, 2020 (GLOBE NEWSWIRE) — Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today it has achieved design lock and shipped its C-band filter for the drone market supporting unmanned aircraft systems (UAS). The filters will be used for control and non-payload communication (CNPC) links.This announcement marks the 12th design locked XBAWTM filter that Akoustis has produced, a six-fold increase in catalog filters in the last...

Most Comprehensive Presentation of Orchard Clinical Data to Date; Spans Five Disease Areas and Highlights Broad Applicability of Hematopoietic Stem Cell Gene Therapy ApproachAccepted Abstracts Include Data on Investigational Gene Therapies for Neurometabolic Conditions, Including Updated Interim Data from Proof-of-Concept Trial in OTL-203 for Mucopolysaccharidosis Type IBOSTON and LONDON, April 29, 2020 (GLOBE NEWSWIRE) — Orchard Therapeutics (Nasdaq: ORTX), a global gene therapy leader, today announced eight upcoming presentations from across its neurometabolic, primary immune deficiency and blood disorder franchises at the American Society of Gene & Cell Therapy (ASGCT) 23rd Annual Meeting, which will take place online May 12-15, 2020, marking the company’s most comprehensive presentation of clinical data at a medical meeting...

RAMSEY, N.J. and BOCA RATON, Fla., April 29, 2020 (GLOBE NEWSWIRE) — ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA”), an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and for the prevention of certain infectious diseases, today announced that it will report financial results for the first quarter ended March 31, 2020 on Wednesday, May 6, 2020 after the U.S. financial markets close.  ADMA’s management team will host a live conference call and audio webcast on that date at 4:30 p.m. ET to discuss its financial results and other Company updates.To access the conference call, please dial (855) 884-8773 (local) or (615) 622-8043 (international) at least 10 minutes prior to the start...

MONACO, April 29, 2020 (GLOBE NEWSWIRE) — Costamare Inc. (“Costamare” or the “Company”) (NYSE: CMRE) today reported unaudited financial results for the first quarter ended March 31, 2020 (“Q1 2020”).Net Income of $32.8 million or $0.21 per share in Q1 2020.Adjusted Net Income available to common stockholders(1) of $32.6 million or $0.27 per share in Q1 2020.Voyage Revenues of $121.4 million.Liquidity of $268.4 million as of end Q1 2020 (including our share of cash amounting to $31.0 million held in subsidiaries co-owned with York Capital Management Global Advisors LLC and an affiliated fund (collectively, together with the funds it manages or advises, “York”)).No material balloon payments in 2020(2).Chartered in total 12 vessels over the quarter.Declared dividend of $0.10 per share on its common stock and dividends on all four classes...

WAYNE, Pa., April 29, 2020 (GLOBE NEWSWIRE) — Liam Kelly, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Merrill Lynch 2020 Health Care Conference on Wednesday, May 13, 2020 at 4:20 p.m. (ET). A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor portion of the Teleflex website at www.teleflex.com.About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology, anesthesia,...

Landsbankinn birtir afkomu fyrst ársfjórðungs 2020 eftir lokun markaðar fimmtudaginn 7. maí 2020.Daginn eftir, þann 8. maí kl. 10:00, mun bankinn bjóða upp á símafund á ensku þar sem farið verður yfir helstu afkomuniðurstöður. Vinsamlegast skráið ykkur á símafundinn með því að senda tölvupóst á netfangið ir@landsbankinn.is.Nánari upplýsingar veitir:Hanna Kristín Thoroddsen, fjárfestatengsl, ir@landsbankinn.is, og í síma: 410 7310

Landsbankinn will publish its financial results for Q1 2020 after market closing on Thursday, 7 May 2020.The following day, 8 May at 10:00 local time, the bank will host an investor call in English covering the main results. Please register to the call by emailing ir@landsbankinn.is.For further information contact:Hanna Kristín Thoroddsen, Investor Relations, ir@landsbankinn.is,  tel: +354 410 7310

FALLS CHURCH, Va., April 29, 2020 (GLOBE NEWSWIRE) — Northrop Grumman Corporation (NYSE: NOC) has released its first quarter 2020 financial results. A copy of the earnings release has been furnished in the company’s Form 8-K filing and is also available on the company’s investor relations website at http://investor.northropgrumman.com.As previously announced, Northrop Grumman will webcast its earnings conference call at 8 a.m. Eastern time today. A live audio broadcast of the conference call will be available on http://investor.northropgrumman.com. To listen to the call, go to the website at least 15 minutes before the call to register, download and install any needed audio software.Northrop Grumman solves the toughest problems in space, aeronautics, defense and cyberspace to meet the ever evolving needs of our customers worldwide....

Ved tidligere meddelelse er det oplyst, at der er truffet beslutning af afvikling af afdeling Danske Small Cap aktier KL – shortname BDIDSCAKLA – ISIN DK0015762249.Finanstilsynet har ved meddelelse af 15. januar 2020 givet tilladelse til afviklingen.Som følge af afviklingen vil afdelingen blev slettet på Nasdaq Copenhagen A/S. Sidste handelsdag vil være mandag den 4. maj 2020.Eventuel henvendelse vedrørende denne meddelelse kan rettes til direktør Tage Fabrin-Brasted, tlf. 44 55 91 60.Med venlig hilsenInvesteringsforeningen BIL DanmarkTage Fabrin-Brasted, direktørVedhæftet filFondsbørsmeddelelse_29_04_2020_afnotering Danske Small Cap aktier

HUHTAMÄKI OYJ STOCK EXCHANGE RELEASE 29.4.2020 AT 13:35Composition of Huhtamäki Oyj’s Board CommitteesThe Board of Directors of Huhtamäki Oyj has resolved upon members of its Committees for a term ending at the end of the next Annual General Meeting.Audit CommitteeAs members of the Audit Committee of the Board of Directors will continue Ms. Anja Korhonen (Chairman), Ms. Kerttu Tuomas and Ms. Sandra Turner.Human Resources CommitteeAs members of the Human Resources Committee of the Board of Directors will continue Mr. Pekka Ala-Pietilä (Chairman), Mr. Doug Baillie, Mr. William R. Barker and Mr. Ralf K. Wunderlich.For further information, please contact:Sami Pauni, Executive Vice President, Corporate Affairs and Legal, Group General Counsel, tel. +358 10 686 7116HUHTAMÄKI OYJGlobal CommunicationsHuhtamaki is a key global player in sustainable...